Hu, Suiyuan
57  results:
Search for persons X
?
 
?
 
?
5

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors an..:

Lv, Fang ; Cai, Xiaoling ; Lin, Chu...
Calcified Tissue International.  113 (2023)  2 - p. 175-185 , 2023
 
?
7

Population attributable fractions of modifiable risk factor..:

Lin, Chu ; Zhu, Xingyun ; Jiao, Ruoyang...
Diabetes, Obesity and Metabolism.  25 (2023)  S1 - p. 5-12 , 2023
 
?
8

Is the steady-state concentration, duration of action, or m..:

Bai, Shuzhen ; Lin, Chu ; Jiao, Ruoyang...
European Journal of Internal Medicine.  109 (2023)  - p. 79-88 , 2023
 
?
12

Association between biologic therapy and fracture incidence..:

Lv, Fang ; Hu, Suiyuan ; Lin, Chu...
Pharmacological Research.  181 (2022)  - p. 106278 , 2022
 
?
 
?
14

SGLT2i increased the plasma fasting glucagon level in patie..:

Zhu, Xingyun ; Lin, Chu ; Li, Li...
European Journal of Pharmacology.  903 (2021)  - p. 174145 , 2021
 
1-15